» Articles » PMID: 29156945

Modulation of Gene Expression in Infrapatellar Fat Pad-Derived Mesenchymal Stem Cells in Osteoarthritis

Overview
Journal Cartilage
Date 2017 Nov 22
PMID 29156945
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Aim In the osteoarthritis (OA) disease, all structures of the joint are involved. The infrapatellar Hoffa fat pad is rich in macrophages and granulocytes, which also represents a source of adipose mesenchymal progenitor cells (ASC) cells. In our study, we analyze how OA affects the ability of ASC-derived from Hoffa's fat pad to differentiate into chondrocytes. Material and methodology We took knee Hoffa's pad samples and adipose tissue from the proximal thigh from 6 patients diagnosed with severe OA and from another 6 patients with an anterior cruciate ligament (ACL) rupture without OA. From all the patients, we took subcutaneous adipose tissue from the thigh, as the control group. Samples of synovial fluid (SF) were also extracted. The gene expression was analyzed by real-time quantitative polymerase chain reaction. Results PTH1R and MMP13 expression during chondrogenic differentiation were similar between OA and ACL groups, while the expression of OPG, FGF2, TGFβ, MMP3 were significantly lower in the OA group. Exposure of differentiated ASC to OA SF induced an increase in the expression of OPG, PTH1R, and MMP13 and a decrease in the expression of FGF2 in cell culture of the ACL group. However, expression of none of these factors was altered by the OA synovial fluid in ASC cells of the OA group. Conclusion OA of the knee also affects the mesenchymal stem cells of Hoffa fat, suggesting that Hoffa fat is a new actor in the OA degenerative process that can contribute to the origin, onset, and progression of the disease.

Citing Articles

Long-term effects of infrapatellar fat pad SVF infiltration in knee osteoarthritis management: A prospective cohort study.

Labarre K, Zimmermann G Bone Rep. 2025; 24:101827.

PMID: 39911147 PMC: 11795827. DOI: 10.1016/j.bonr.2025.101827.


Basic Properties of Adipose-Derived Mesenchymal Stem Cells of Rheumatoid Arthritis and Osteoarthritis Patients.

Kuca-Warnawin E, Kurowska W, Plebanczyk M, Wajda A, Kornatka A, Burakowski T Pharmaceutics. 2023; 15(3).

PMID: 36986863 PMC: 10051260. DOI: 10.3390/pharmaceutics15031003.


Presence of a t(12;18)(q14;q21) Chromosome Translocation and Fusion of the Genes for High-mobility Group AT-Hook 2 () and WNT Inhibitory Factor 1 () in Infrapatellar Fat Pad Cells from a Patient With Hoffa's Disease.

Panagopoulos I, Andersen K, Gorunova L, Eilert-Olsen M, Lund-Iversen M, Wessel-Aas T Cancer Genomics Proteomics. 2022; 19(5):584-590.

PMID: 35985683 PMC: 9353724. DOI: 10.21873/cgp.20343.


Instructive cartilage regeneration modalities with advanced therapeutic implantations under abnormal conditions.

Wang Z, Le H, Wang Y, Liu H, Li Z, Yang X Bioact Mater. 2022; 11:317-338.

PMID: 34977434 PMC: 8671106. DOI: 10.1016/j.bioactmat.2021.10.002.


Editorial: One Step at a Time: Advances in Osteoarthritis.

Mobasheri A, Trumble T, Byron C Front Vet Sci. 2021; 8:727477.

PMID: 34336985 PMC: 8322576. DOI: 10.3389/fvets.2021.727477.


References
1.
Goomer R, Maris T, Gelberman R, Boyer M, Silva M, Amiel D . Nonviral in vivo gene therapy for tissue engineering of articular cartilage and tendon repair. Clin Orthop Relat Res. 2000; (379 Suppl):S189-200. DOI: 10.1097/00003086-200010001-00025. View

2.
Wei W, Rudjito E, Fahy N, Verhaar J, Clockaerts S, Bastiaansen-Jenniskens Y . The infrapatellar fat pad from diseased joints inhibits chondrogenesis of mesenchymal stem cells. Eur Cell Mater. 2015; 30:303-14. DOI: 10.22203/ecm.v030a21. View

3.
Gavrilovic J . Fibroblast growth factor 2: A new key player in osteoarthritis. Arthritis Rheum. 2009; 60(7):1869-72. DOI: 10.1002/art.24657. View

4.
Ozeki N, Muneta T, Matsuta S, Koga H, Nakagawa Y, Mizuno M . Synovial mesenchymal stem cells promote meniscus regeneration augmented by an autologous Achilles tendon graft in a rat partial meniscus defect model. Stem Cells. 2015; 33(6):1927-38. PMC: 4497612. DOI: 10.1002/stem.2030. View

5.
Chia S, Sawaji Y, Burleigh A, McLean C, Inglis J, Saklatvala J . Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum. 2009; 60(7):2019-27. DOI: 10.1002/art.24654. View